top of page
2025
Adoption of microfluidic MEA technology for electrophysiology of 3D neuronal networks exposed to suborbital conditions. Link


2024
Fibrin-polycaprolactone scaffolds for the differentiation of human neural progenitor cells into dopaminergic neurons. Link

Materials Characterization of Stereolithography 3D Printed Polymer to Develop a Self-Driven Microfluidic Device for Bioanalytical Applications. Link

2023
Microcomputed Tomography for the Microstructure Evaluation of 3D Bioprinted Scaffolds. Link

Inhibition of ERK 1/2 pathway downregulates YAP1/TAZ signaling in human cardiomyocytes exposed to hyperglycemic conditions. Link

Development of in vitro cardiovascular tissue models within capillary circuit microfluidic devices fabricated with 3D stereolithography printing. Link

bottom of page